Persisting inequalities in past-year drug use by sexual identity: trends across England's 2007, 2014 and 2024 Adult Psychiatric Morbidity Surveys
- 1City St George's, University of London
Abstract
Introduction Sexual minority people experience disproportionate discrimination and minority stress, contributing to poorer health and health-related behaviours, including drug use. Increasing drug potency and adulteration may heighten associated harms. UK evidence on sexual identity inequalities in drug use is dated, and whether inequalities have changed over time is unclear. Methods Adult Psychiatric Morbidity Surveys 2007 (N=7403), 2014 (N=7546) and 2024 (N=6912) provide repeated cross-sectional probability samples of the household population of England. Weighted prevalence of past-year drug use was analysed by sexual identity, sex and age. Logistic regression adjusted for age, sex and area deprivation. Trends focused on 16-64-year-olds. Results In 2024, past-year drug use among adults 16+ was reported by: 9.1% heterosexual, 18.3% gay/lesbian, 26.8% bisexual, 28.3% other identity adults. Among 16-64-year-olds, drug use in sexual minority adults (2007=22.9%, 2014=27.5%, 2024=24.9%) remained at least double that of heterosexual adults (2007=10.3%, 2014=9.9%, 2024=11.6%), with adjusted odds ratios of 2.4 (95% CI:1.7-3.2, 2007), 3.2 (2.2-4.8, 2014) and 2.2 (1.4-3.4, 2024). The gap between sexual minority and heterosexual women appeared to widen, although confidence intervals were wide. Conclusions Sexual identity inequalities in drug use persisted over 17 years in England. Prevention, treatment and policies should address these inequalities and their social determinants including discrimination and exclusion. Routine drug statistics should be reported by sexual identity. Health surveys should collect gender identity and be large enough to enable disaggregation of sexual and gender identities.
Related
- Psychosocial Stressors and Psychiatric Morbidity Among Afghan Refugees Attending a Psychiatry Clinic in Islamabad, Pakistan: A Descriptive Cross-Sectional Study
- Sustained Viral Suppression and its association with Psychiatric Morbidity and Sleep Quality among Older Adults with Human Immunodeficiency Virus: Evidence from a Retrospective Cohort in Ibadan, Nigeria.
- Health-Related Quality of Life and Psychiatric Morbidity at Follow-up After Catheter Ablation in Children with Supraventricular Tachycardia
- Psychiatric comorbidity in dissociative identity disorder: A meta-analysis
- Inequalities and practice-level predictors of cancer diagnostic activity: longitudinal study in England
BibTeX
@misc{wu2026persisting,
title = {{Persisting inequalities in past-year drug use by sexual identity: trends across England's 2007, 2014 and 2024 Adult Psychiatric Morbidity Surveys}},
author = {Y. Wu and J. Das-Munshi and J. Strang and E. Roberts and A. Khanolkar and L. Becares and S. McManus},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.05.26367385},
url = {https://www.medrxiv.org/content/10.64898/2026.11.05.26367385v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Persisting inequalities in past-year drug use by sexual identity: trends across England's 2007, 2014 and 2024 Adult Psychiatric Morbidity Surveys
AU - Y. Wu
AU - J. Das-Munshi
AU - J. Strang
AU - E. Roberts
AU - A. Khanolkar
AU - L. Becares
AU - S. McManus
PY - 2026
DA - 2026/11/05
PB - medRxiv
DO - 10.64898/2026.11.05.26367385
UR - https://www.medrxiv.org/content/10.64898/2026.11.05.26367385v1
AB - Introduction Sexual minority people experience disproportionate discrimination and minority stress, contributing to poorer health and health-related behaviours, including drug use. Increasing drug potency and adulteration may heighten associated harms. UK evidence on sexual identity inequalities in drug use is dated, and whether inequalities have changed over time is unclear. Methods Adult Psychiatric Morbidity Surveys 2007 (N=7403), 2014 (N=7546) and 2024 (N=6912) provide repeated cross-sectional probability samples of the household population of England. Weighted prevalence of past-year drug use was analysed by sexual identity, sex and age. Logistic regression adjusted for age, sex and area deprivation. Trends focused on 16-64-year-olds. Results In 2024, past-year drug use among adults 16+ was reported by: 9.1% heterosexual, 18.3% gay/lesbian, 26.8% bisexual, 28.3% other identity adults. Among 16-64-year-olds, drug use in sexual minority adults (2007=22.9%, 2014=27.5%, 2024=24.9%) remained at least double that of heterosexual adults (2007=10.3%, 2014=9.9%, 2024=11.6%), with adjusted odds ratios of 2.4 (95% CI:1.7-3.2, 2007), 3.2 (2.2-4.8, 2014) and 2.2 (1.4-3.4, 2024). The gap between sexual minority and heterosexual women appeared to widen, although confidence intervals were wide. Conclusions Sexual identity inequalities in drug use persisted over 17 years in England. Prevention, treatment and policies should address these inequalities and their social determinants including discrimination and exclusion. Routine drug statistics should be reported by sexual identity. Health surveys should collect gender identity and be large enough to enable disaggregation of sexual and gender identities.
ER -